Do I Have Fibromyalgia? Genetic Screening Test In Allentown, PA Helps You Know

Jun 9, 2022

Avrio Genetics (267-329-9319) in Allentown, PA helps you determine whether you’re at risk for fibromyalgia. We’ve recently launched a new genetic screening test for the condition.

Do I Have Fibromyalgia? Genetic Screening Test In Allentown, PA Helps You Know

The first step to any treatment program is detection. You need to know if you have an illness - or are at risk of developing it - in order to develop a treatment plan for it. We take the guesswork out at Avrio Genetics, where your health is always thoroughly checked.

With this in mind, we’re proud to announce our newest test: the FibroKit Lite powered by Pronecea. The new test helps you determine your risk for fibromyalgia.

It takes into consideration the ever-increasing number of fibromyalgia patients in America. To date, there are around 4 million US adults, or about 2% of the adult population, who suffer from the condition. Experts expect this number to rise in the next few years, although they are still determining the reasons why.

Learn more about it at https://avriogenetics.com/fibro-kit-lite

The condition is considered a lifelong illness that can be effectively managed through proper medication and lifestyle changes. Studies have shown that early detection can lead to better management plans; still, many patients are misdiagnosed because of inadequate fibromyalgia screening facilities and tests.

Our FibroKit Lite powered by Pronacera is a state-of-the-art tool for managing fibromyalgia symptoms. The genetic screening test assesses two parameters that are linked to the onset and advancement of the disease’s symptoms. These are mitochondria health and intestinal microbiota.

Mitochondria are key to controlling oxidative stress and inflammation. When it doesn’t function properly, it can lead to central and peripheral sensitization typically seen in fibromyalgia.

On the other hand, intestinal microbiota has been studied to be closely linked to the condition. Studies have shown that changes to the intestinal barrier of the microbiota can trigger immunological consequences such as autoimmune disorders.

The new test determines the health of these two factors. If either is considered to be compromised, you are more vulnerable to developing the disease.

This is important! As we mentioned before, the first step to any treatment plan is knowing whether you have a disease or not. Our FibroKit Lite gives you the insight you need to begin visiting a doctor specializing in fibromyalgia!

FibroKit Lite is not limited to detection. The screening test can also be used for prevention, as doctors will be able to anticipate the negative progression of your symptoms, if any, and customize a treatment plan for you based on the results of the test.

FibroKit Lite is recommended for those who suffer from chronic generalized pain, present gastrointestinal problems without clinical cause, or who have a history of the condition in their family.

We are the leading genetics screening center in Allentown, PA, and we specialize in packages for couples looking to conceive.

Go to https://avriogenetics.com so you can learn more.

Web Analytics